Dr. Yasmine Hisham is a Regulatory Affairs professional and Manager of the Evaluation Unit of registration files for imported human pharmaceuticals within the Egyptian Drug Authority.

Dr. Yasmine has solid experience in the assessment of small molecule pharmaceuticals, with a focus on dossier evaluation, lifecycle management, and regulatory compliance. In her role, she contributes to enhancing review efficiency and supports regulatory initiatives aligned with international best practices.

Dr. Yasmine is particularly interested in regulatory harmonization and reliance approaches to improve timely access to safe and effective medicine.